Symptomatic toxoplasma infection due to congenital and postnatally acquired infection

Archives of Disease in Childhood

Volumn 91, Issue 6, 2006, Pages 495-498

  Gilbert, R ^a   Tan, H K ^a   Cliffe, S ^a   Guy, E ^b   Stanford, M ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH WALES   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHORIORETINITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL INFECTION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; HUMAN; INCIDENCE; PERINATAL PERIOD; PRIORITY JOURNAL; SYMPTOMATOLOGY; TOXOPLASMOSIS;

ABORTION, SPONTANEOUS; ANIMALS; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DISEASE TRANSMISSION, VERTICAL; ENGLAND; FEMALE; FETAL DEATH; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; TOXOPLASMOSIS, OCULAR;

EID: 33744800262     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.088385     Document Type: Article

References (29)

1. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142-7.
2. Gras L, Gilbert RE, Ades AE, et al. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001;30:1309-30.
3. Freeman K, Salt A, Prusa A, et al. Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns and impairments, in 3 year old children. Biomed Central Pediatrics 2005;5:23.
4. Gras L, Wallon M, Pollak A, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers. Acta Paediatr Scand 2005;94:1-12.
5. Binquet C, Wallon M, Quantin C, et al. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 2003;131:1157-68.
6. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen 2002;9:135-41.
7. Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003;110:112-20.
8. Foulon W, Pinon J-M, Stray-Pedersen B, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 1999;181:843-7.
9. Guerina NG, Ho-Wen H, Meissner HC, et al. Neonatal screening and early treatment for congenital Toxoplasma gondii infection. New Engl J Med 1994;330:1858-63.
10. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-7.
11. Neto EC, Anele E, Rubim R, et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol 2000;29:941-7.
12. Nicoll A, Lynn R, Rahi J, et al. Public health outputs from the British Paediatric Surveillance Unit and similar clinician-based systems. J R Soc Med 2000;93:580-5.
13. Foot B, Stanford M, Rahi J, et al. The British Ophthalmological Surveillance Unit: an evaluation of the first 3 years. Eye 2003;17:9-15.
14. Lebech M, Joynson DH, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenially infected offspring. Eur J Clin Microbiol Infect Dis 1996;15:799-805.
15. Agresti A. Simple capture-recapture models permitting unequal catchability and variable sampling effort. Biometrics 1994;50:494-500.
16. Petersen E, Schmidt DR. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev Anti Infect Ther 2003;1:175-82.
17. Gilbert RE, See SE, Jones LV, et al. Antibiotics for treating and preventing toxoplasma retinochoroiditis. The Cochrane Library, 2002;issue 3.
18. Jones JL, Dietz VJ, Power M, et al. Survey of obstetrician-gynecologists in the United States about toxoplasmosis. Infect Dis Obstet Gynecol 2001;9:23-31.
19. Liesenfeld O, Montoya JG, Tathineni NJ, et al. Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol 2001;184:140-5.
20. Welton N J, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. JRSS (C) Applied Statistics 2005;54:385-404.
21. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003;136:973-88.
22. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, et al. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerging Infect Dis 2003;9:55-62.
23. Freeman K, Oakley L, Pollak A, et al. Congenital toxoplasmosis and preterm birth, low birth weight, and small for gestational age birth. BJOG 2004;112:31-7.
24. Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 2000;84:224-6.
25. Burnett AJ, Shortt SG, Isaac Renton J, et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998;105:1032-7.
26. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858-63.
27. Evengard B, Petterson K, Engman M-L, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001;127:121-7.
28. Hall SM. Congenital toxoplasmosis. BMJ 1992;305:291-7.
29. Gilbert RE, Dunn D, Lightman S, et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999;123:283-9.